HepQuant is a Denver-based company that specializes in developing non-invasive, quantitative tests to measure liver health. Their flagship product, the HepQuant DuO Test, provides healthcare providers with valuable information about liver cell function and portal-systemic shunting, which are crucial factors in managing patients with liver diseases effectively. The test results can aid physicians in making decisions regarding invasive procedures, monitoring treatment response, and predicting disease progression and adverse outcomes.
With an estimated 30 to 40 million Americans suffering from some form of liver disease, HepQuant's innovative liver function tests play a vital role in identifying individuals at risk for developing chronic liver disease. Their tests directly measure liver health, allowing doctors to risk stratify patients, make informed treatment decisions, and monitor the efficacy of therapy or disease progression. HepQuant's mission is to improve the lives of people with liver diseases by providing accurate and non-invasive tools for assessing liver health.
Generated from the website